PTCT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PTCT Shares Outstanding History and PTCT YTD Return |
PTCT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PTCT Shares Outstanding History and PTCT YTD Return |
PTCT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+18.09% CAGR Mouse over chart for data details
|
PTCT Stock Price Chart |
About PTC Therapeutics Inc |
PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of medicines. Co. has a portfolio pipeline that includes several commercial products and product candidates focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. Co. has two products, Translarna (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, or DMD. Translarna is designed for the treatment of nonsense mutation DMD in ambulatory patients aged two years and older Emflaza is designed for the treatment of DMD in patients two years and older. We show 44 historical shares outstanding datapoints in our PTCT shares outstanding history coverage, used to compute PTCT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PTCT market cap history over the course of time is important for investors interested in comparing PTCT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PTCT versus a peer is one thing; comparing PTCT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PTCT can fluctuate over the course of history. With this page we aim to empower investors researching PTCT by allowing them to research the PTCT market cap history. |
PTCT Current Stock Quote |
Free PTCT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
PTCT Share Performance |
Market Cap Peers |
PTC Therapeutics (PTCT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
PTE Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.